NANOVIRICIDES, INC. Financing Cash Flow
NANOVIRICIDES, INC. (NNVC) reported Financing Cash Flow of $7.31 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-05-15
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$6.74K, a 101.17% decline year-over-year.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.07M, a 166.11% increase year-over-year.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.25M, a 27.18% decline year-over-year.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $728.08K, a 76.66% decline year-over-year.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for fiscal 2025 was $5.30M, a 69.76% increase from fiscal 2024.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for fiscal 2024 was $3.12M.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$94.79K.
- NANOVIRICIDES, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$234.72K, a 101.54% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 77 month | Net Cash Provided by (Used in) Financing Activities 80 month | Net Cash Provided by (Used in) Financing Activities 83 month | Net Cash Provided by (Used in) Financing Activities 86 month | Net Cash Provided by (Used in) Financing Activities 89 month | Net Cash Provided by (Used in) Financing Activities 92 month | Net Cash Provided by (Used in) Financing Activities 95 month | Net Cash Provided by (Used in) Financing Activities 99 month | Net Cash Provided by (Used in) Financing Activities 101 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$6.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $6.07M derived: sum of 2 quarters · filed 2026-05-15 | $7.31M 10-Q · filed 2026-05-15 | $8.04M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||
| 2025-12-31 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $7.32M 10-Q · filed 2026-02-17 | $8.05M derived: sum of 3 quarters · filed 2026-02-17 | $8.62M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||
| 2025-09-30 | $1.25M 10-Q · filed 2025-11-14 | $1.97M derived: sum of 2 quarters · filed 2025-11-14 | $2.55M derived: sum of 3 quarters · filed 2026-05-15 | $4.83M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||
| 2025-06-30 | $728.08K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $1.30M derived: sum of 2 quarters · filed 2026-05-15 | $3.59M derived: sum of 3 quarters · filed 2026-05-15 | $5.30M 10-K · filed 2025-09-29 | ||||||||||
| 2025-03-31 | $575.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $2.86M derived: sum of 2 quarters · filed 2026-05-15 | $4.57M 10-Q · filed 2026-05-15 | $7.69M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||
| 2024-12-31 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | $3.99M 10-Q · filed 2026-02-17 | $7.11M derived: sum of 3 quarters · filed 2026-02-17 | $7.11M derived: sum of 4 quarters · filed 2026-02-17 | ||||||||||
| 2024-09-30 | $1.71M 10-Q · filed 2025-11-14 | $4.83M derived: sum of 2 quarters · filed 2025-11-14 | $4.83M derived: sum of 3 quarters · filed 2025-11-14 | $4.83M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||
| 2024-06-30 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $3.12M derived: sum of 2 quarters · filed 2025-09-29 | $3.12M derived: sum of 3 quarters · filed 2025-09-29 | $3.12M 10-K · filed 2025-09-29 | ||||||||||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | $0.00 10-Q · filed 2025-02-14 | $0.00 derived: sum of 3 quarters · filed 2025-02-14 | $0.00 derived: sum of 4 quarters · filed 2025-02-14 | ||||||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 derived: sum of 3 quarters · filed 2024-11-14 | -$23.84K derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $0.00 derived: sum of 2 quarters · filed 2024-09-27 | -$23.84K derived: sum of 3 quarters · filed 2024-09-27 | -$94.79K 10-K · filed 2024-09-27 | ||||||||||
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$23.84K derived: sum of 2 quarters · filed 2024-05-15 | -$94.79K 10-Q · filed 2024-05-15 | -$127.50K derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||
| 2022-12-31 | -$23.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$94.79K 10-Q · filed 2024-02-14 | -$127.50K derived: sum of 3 quarters · filed 2024-02-14 | -$196.79K derived: sum of 4 quarters · filed 2024-02-14 | ||||||||||
| 2022-09-30 | -$70.95K 10-Q · filed 2022-11-14 | -$103.66K derived: sum of 2 quarters · filed 2023-10-13 | -$172.95K derived: sum of 3 quarters · filed 2023-10-13 | -$234.33K derived: sum of 4 quarters · filed 2023-10-13 | ||||||||||
| 2022-06-30 | -$32.71K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | -$102.00K derived: sum of 2 quarters · filed 2023-10-13 | -$163.38K derived: sum of 3 quarters · filed 2023-10-13 | -$234.72K 10-K · filed 2023-10-13 | ||||||||||
| 2022-03-31 | -$69.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$130.67K derived: sum of 2 quarters · filed 2023-05-15 | -$202.01K 10-Q · filed 2023-05-15 | -$272.51K derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||
| 2021-12-31 | -$61.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$132.71K 10-Q · filed 2023-02-14 | -$203.21K derived: sum of 3 quarters · filed 2023-02-14 | $5.85M derived: sum of 4 quarters · filed 2023-02-14 | ||||||||||
| 2021-09-30 | -$71.34K 10-Q · filed 2022-11-14 | -$141.84K derived: sum of 2 quarters · filed 2022-11-14 | $5.91M derived: sum of 3 quarters · filed 2022-11-14 | $4.84M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-06-30 | -$70.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | $5.98M derived: sum of 2 quarters · filed 2022-10-13 | $4.91M derived: sum of 3 quarters · filed 2022-10-13 | $15.26M 10-K · filed 2022-10-13 | ||||||||||
| 2021-03-31 | $6.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $4.98M derived: sum of 2 quarters · filed 2022-05-16 | $15.33M 10-Q · filed 2022-05-16 | $24.65M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||
| 2020-12-31 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $9.28M 10-Q · filed 2022-02-14 | $18.60M derived: sum of 3 quarters · filed 2022-02-14 | $26.39M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||
| 2020-09-30 | $10.35M 10-Q · filed 2021-11-15 | $19.67M derived: sum of 2 quarters · filed 2021-11-15 | $27.46M derived: sum of 3 quarters · filed 2021-11-15 | $28.42M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2020-06-30 | $9.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $17.11M derived: sum of 2 quarters · filed 2021-10-12 | $18.07M derived: sum of 3 quarters · filed 2021-10-12 | $17.83M 10-K · filed 2021-10-12 | ||||||||||
| 2020-03-31 | $7.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | $8.75M derived: sum of 2 quarters · filed 2021-05-14 | $8.51M 10-Q · filed 2021-05-14 | $8.67M 10-Q · filed 2020-06-22 | $8.51M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||
| 2019-12-31 | $958.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $716.83K 10-Q · filed 2021-02-16 | $716.83K derived: sum of 3 quarters · filed 2021-10-12 | $3.07M derived: sum of 4 quarters · filed 2021-10-12 | ||||||||||
| 2019-09-30 | -$242.10K 10-Q · filed 2020-11-16 | -$242.10K derived: sum of 2 quarters · filed 2021-10-12 | $2.11M derived: sum of 3 quarters · filed 2021-10-12 | |||||||||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | $2.35M derived: sum of 2 quarters · filed 2021-10-12 | $2.35M 10-K · filed 2021-10-12 | |||||||||||
| 2019-03-31 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22 | $2.35M 10-Q · filed 2020-06-22 | ||||||||||||
| 2018-12-31 | $0.00 10-Q · filed 2020-02-14 | |||||||||||||
| 2018-06-30 | $0.00 10-K · filed 2020-10-13 | |||||||||||||
| 2017-06-30 | -$1.00M 10-K · filed 2019-08-23 | |||||||||||||
| 2013-09-30 | $9.88M 10-Q/A · filed 2013-11-18 | $52.72M 10-Q/A · filed 2013-11-18 | ||||||||||||
| 2013-06-30 | $6.51M 10-K/A · filed 2013-10-08 | $42.85M 10-K/A · filed 2013-10-08 | ||||||||||||
| 2013-03-31 | $4.29M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | $6.61M derived: sum of 2 quarters · filed 2013-05-20 | $6.61M 10-Q/A · filed 2013-05-20 | $8.80M derived: sum of 4 quarters · filed 2013-11-18 | $42.95M 10-Q/A · filed 2013-05-20 | |||||||||
| 2012-12-31 | $2.32M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-02-22 | $2.32M 10-Q/A · filed 2013-02-22 | $4.51M derived: sum of 3 quarters · filed 2013-11-18 | $6.83M derived: sum of 4 quarters · filed 2013-11-18 | $38.66M 10-Q/A · filed 2013-02-22 | |||||||||
| 2012-09-30 | $0.00 10-Q/A · filed 2013-11-18 | $2.19M derived: sum of 2 quarters · filed 2013-11-18 | $4.50M derived: sum of 3 quarters · filed 2013-11-18 | $6.97M derived: sum of 4 quarters · filed 2013-11-18 | $36.34M 10-Q · filed 2012-11-19 | |||||||||
| 2012-06-30 | $2.19M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2013-10-08 | $4.50M derived: sum of 2 quarters · filed 2013-10-08 | $6.97M derived: sum of 3 quarters · filed 2013-10-08 | $9.33M 10-K/A · filed 2013-10-08 | $36.34M 10-K/A · filed 2012-10-26 | |||||||||
| 2012-03-31 | $2.32M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | $4.78M derived: sum of 2 quarters · filed 2013-05-20 | $7.14M 10-Q/A · filed 2013-05-20 | $9.47M derived: sum of 4 quarters · filed 2013-05-20 | $34.15M 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | $2.46M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-22 | $4.82M 10-Q/A · filed 2013-02-22 | $7.15M derived: sum of 3 quarters · filed 2013-02-22 | $7.17M derived: sum of 4 quarters · filed 2013-02-22 | $31.83M 10-Q · filed 2012-02-14 | |||||||||
| 2011-09-30 | $2.36M 10-Q · filed 2012-11-19 | $4.69M derived: sum of 2 quarters · filed 2012-11-19 | $4.71M derived: sum of 3 quarters · filed 2012-11-19 | $7.04M derived: sum of 4 quarters · filed 2012-11-19 | $29.37M 10-Q/A · filed 2011-12-12 | |||||||||
| 2011-06-30 | $2.33M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $2.35M derived: sum of 2 quarters · filed 2012-10-26 | $4.67M derived: sum of 3 quarters · filed 2012-10-26 | $6.97M 10-K/A · filed 2012-10-26 | ||||||||||
| 2011-03-31 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $2.35M derived: sum of 2 quarters · filed 2012-05-21 | $4.64M 10-Q · filed 2012-05-21 | |||||||||||
| 2010-12-31 | $2.33M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | $4.62M 10-Q · filed 2012-02-14 | ||||||||||||
| 2010-09-30 | $2.29M 10-Q/A · filed 2011-12-12 | |||||||||||||
| 2010-06-30 | $8.06M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |